pAMPK changes the NAD+ abundance and the NAD+/NADH ratio to upregulate Sirt1 [57], which in turn plays beneficial roles in modulating hepatic lipid metabolism, hepatic oxidative stress, and mediating hepatic inflammation through deacetylating some transcriptional regulators against the progression of fatty liver diseases [20]. This evidence concerns the gene SIRT1 and fatty liver disease.